Barclays’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-19,524
| Closed | -$4.24M | – | 5195 |
|
|
2021
Q1 | $4.24M | Sell |
19,524
-14,603
| -43% | -$2.74M | ﹤0.01% | 1655 |
|
|
2020
Q4 | $3.94M | Sell |
34,127
-2,693
| -7% | -$302K | ﹤0.01% | 1689 |
|
|
2020
Q3 | $3.58M | Buy |
36,820
+16,738
| +83% | +$1.93M | ﹤0.01% | 1634 |
|
|
2020
Q2 | $2.46M | Sell |
20,082
-10,870
| -35% | -$1.23M | ﹤0.01% | 1918 |
|
|
2020
Q1 | $2.71M | Sell |
30,952
-8,197
| -21% | -$868K | ﹤0.01% | 2005 |
|
|
2019
Q4 | $4.09M | Sell |
39,149
-20,895
| -35% | -$2.34M | ﹤0.01% | 2229 |
|
|
2019
Q3 | $6.91M | Buy |
60,044
+37,292
| +164% | +$5.66M | ﹤0.01% | 1590 |
|
|
2019
Q2 | $3.92M | Sell |
22,752
-206,456
| -90% | -$35.7M | ﹤0.01% | 2099 |
|
|
2019
Q1 | $38.6M | Sell |
229,208
-430,647
| -65% | -$64.1M | 0.03% | 532 |
|
|
2018
Q4 | $64.3M | Buy |
659,855
+430,220
| +187% | +$56.4M | 0.05% | 296 |
|
|
2018
Q3 | $39.7M | Sell |
229,635
-131,334
| -36% | -$18.9M | 0.03% | 513 |
|
|
2018
Q2 | $50.4M | Buy |
360,969
+178,255
| +98% | +$25.3M | 0.04% | 357 |
|
|
2018
Q1 | $20.6M | Buy |
182,714
+175,014
| +2,273% | +$22M | 0.02% | 832 |
|
|
2017
Q4 | $1.02M | Sell |
7,700
-9,100
| -54% | -$1.07M | ﹤0.01% | 3095 |
|
|
2017
Q3 | $1.71M | Buy |
16,800
+14,000
| +500% | +$1.5M | ﹤0.01% | 2504 |
|
|
2017
Q2 | $280K | Sell |
2,800
-32,200
| -92% | -$3.47M | ﹤0.01% | 4074 |
|
|
2017
Q1 | $4.23M | Sell |
35,000
-98,717
| -74% | -$12.1M | ﹤0.01% | 1450 |
|
|
2016
Q4 | $14.9M | Buy |
+133,717
| New | +$16.1M | 0.02% | 745 |
|
|
2016
Q1 | – | Sell |
-9,952
| Closed | -$546K | – | 6568 |
|
|
2015
Q4 | $686K | Buy |
9,952
+6,791
| +215% | +$553K | ﹤0.01% | 2943 |
|
|
2015
Q3 | $288K | Buy |
+3,161
| New | +$351K | ﹤0.01% | 3829 |
|
|
2015
Q2 | – | Sell |
-104
| Closed | -$9K | – | 7295 |
|
|
2015
Q1 | $9K | Buy |
+104
| New | +$8.45K | ﹤0.01% | 6301 |
|
|
2014
Q4 | – | Sell |
-118
| Closed | -$9K | – | 7727 |
|
|
2014
Q3 | $9K | Buy |
+118
| New | +$10.4K | ﹤0.01% | 6961 |
|
|
2014
Q2 | – | Sell |
-17
| Closed | -$1K | – | 7877 |
|
|
2014
Q1 | $1K | Sell |
17
-28,883
| -100% | -$1.72M | ﹤0.01% | 7510 |
|
|
2013
Q4 | $1.19M | Buy |
+28,900
| New | +$914K | ﹤0.01% | 3206 |
|
Other funds holding GWPH
Barclays's GWPH Position: Q2 2021 in Review
Barclays sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 19,524 shares — an estimated $4.24M sold.
Barclays first reported a position in GWPH in Q4 2013 and held it in 24 quarters. The position peaked at $64.3M in Q4 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Barclays reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Barclays sold 19,524 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $4.24M.
- Barclays first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2013 and held it in 24 quarters.
- Barclays's GW Pharmaceuticals Plc American Depositary Shares position peaked at $64.3M in Q4 2018.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.